TipRanks
Go Ultimate55% OFF

Livzon Pharmaceutical Group (1513) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
H001 Capsule 200Mg-Qd, Enoxaparin Sodium Injection, H001 Capsule 300Mg-Qd, H001 Capsule 200Mg-BidCirculatory DiseasePhase IIRecruitingPhase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee ArthroplastyApr 30, 2025―
Jp-1366 Simulation Tablets, Esomeprazole Magnesium (Nexium) Simulation TabletsReflux Esophagitis (Re)Phase IIIRecruitingA Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux EsophagitisFeb 07, 2025―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Livzon Pharmaceutical Group Class H (HK:1513) have in its pipeline
Livzon Pharmaceutical Group HK:1513 is currently developing the following drugs: H001 Capsule 200Mg-Qd, Enoxaparin Sodium Injection, H001 Capsule 300Mg-Qd, H001 Capsule 200Mg-Bid, Jp-1366 Simulation Tablets, Esomeprazole Magnesium (Nexium) Simulation Tablets. These drug candidates are in various stages of clinical development as the company works toward FDA approval.